Avsnitt
-
May 6, 2026
ATS 2026 PR Assembly: Roadmap & Session Highlights, A Guide to the ATS 2026 PR Assembly Sessions
https://craftprd1.blob.core.windows.net/documents/membership/assemblies/pr/ATS-PR-Assembly-Roadmap-2026-Slides.pdfAlan L. Hamilton, PhD, ATS PR Program Committee Chair (Incoming)
Dmitry Rozenberg, MD, PhD, ATS PR Web Committee Co-Chair00:00 — Introduction & Podcast Opening
00:15 — Overview of ATS 2026 PR Assembly Program
01:15 — Saturday & Sunday Sessions Highlights
02:58 — Monday Programming & Membership Meeting
04:33 — Tuesday Sessions & Closing Remarks -
March 2, 2026
In this episode, we explore a topic essential to every ATS member and their patients: Basic Science and Lab Research Sustainability. Hosted by Miles D. Hagner, MD, of the ATS Early Career Professionals Working Group (Assembly on Allergy, Immunology, and Inflammation), this discussion brings together experts Dr. Emma Thornell and Emily Colpack to examine how laboratory research can reduce environmental impact without compromising scientific rigor.
Emma Thornell, PhD, is a research assistant professor at the University of Iowa, where she studies the intersection of lung disease and environmental exposures. Emily Colpack, MPA, serves as Sustainability Lead and My Green Labs Coordinator at the University of Alabama at Birmingham. Both lead initiatives aimed at improving the sustainability of laboratory research.
Topics covered include optimizing ultra‑low temperature freezers and fume hoods, coordinating shared operations such as autoclaves, and appropriate use of biohazardous waste areas. Ultimately, the panel offers several practical strategies, with an emphasis on lab education, for making scientific research more sustainable—without slowing the pace of discovery.00:00:00 – 00:00:15 Podcast Introduction & Opening Music
00:00:15 – 00:00:42 Welcome & Guest Introductions
00:00:42 – 00:01:13 Dr. Emma Thornell’s Background & Research
00:01:13 – 00:01:58 Emily Colpack’s Role in Sustainability & Green Labs
00:01:58 – 00:02:59 What Sustainability Means in Scientific Research
00:02:59 – 00:04:15 Environmental Impact of Lab Work (Energy, Water, Emissions)
00:04:15 – 00:05:55 How Labs Measure Their Environmental Footprint
00:05:55 – 00:07:48 Biggest Energy Drains in the Lab (Freezers, Hoods, Autoclaves)
00:07:48 – 00:10:55 Practical Ways to Reduce Lab Energy Use
00:10:55 – 00:43:26 Improving Sustainability: Programs, Culture Change & Real-World ImpactHost:
Miles D. Hagner, MD
Pulmonary/Critical Care Medicine Faculty
University of Iowa Hospitals and ClinicsGuests:
Emily Colpack, MPA
University of Alabama BirminghamEmma Thornell, PhD
University of Iowa Hospitals and Clinics -
Saknas det avsnitt?
-
We’re joined by the chairs of the ATS Pulmonary Circulation Assembly, Drs. Soban Umar and Harry Karmouty-Quintana, to highlight all the PC sessions at the upcoming conference in Orlando.
Hosts:
Khushboo Goel, MD
Assistant Professor of Medicine
Cedars-Sinai Medical Center
Kathryn del Valle, MD
Assistant Professor of Medicine
Mayo Clinic, Rochester
Guests:
Soban Umar, MD PhD
Professor, Department of Anesthesiology
University of California, Los Angeles
Harry Karmouty-Quintana, PhD
Associate Professor
Director, UTHealth Houston Pulmonary Center of Excellence
University of Texas, Houston
McGovern Medical School
00:00 – 00:15 | Podcast Introduction & Welcome
00:15 – 00:35 | Episode Focus: ATS 2026 Preview
00:35 – 01:12 | Meet the Guests
01:12 – 02:03 | Program Committee Overview
02:03 – 03:11 | ATS 2026 Theme: Lung Microenvironment
03:11 – 04:01 | Highlighted Scientific Sessions
04:01 – 06:03 | Session Types & Program Structure
06:03 – 08:05 | Featured Sessions & Collaborations
08:05 – 10:18 | Postgraduate Courses & Expert Sessions
10:18 – 23:04 | ATS Tips, Networking & Closing -
March 11, 2026
How to Develop Your ATS Document Proposal - An introduction to the documents development process
Assembly - Clinical Problems
Host:
Dr. Kerri A. Johannson, MD, MPH, FRCPC, ATSF
Associate Professor
Departments of Medicine & Community Health Sciences
Snyder Institute for Chronic Diseases
Research Director, Interstitial Lung Disease Program
University of Calgary, Calgary AB Canada
Guests:
Jolene Fisher, MD, MSc, FRCPC
Respirology and Interstitial Lung Disease
Clinician Investigator, University Health Network
Assistant Professor, Department of Medicine, University of Toronto
Research Director, Toronto General Hospital Interstitial Lung Disease Program
Kevin Wilson, MD
ATS Chief of Guidelines and Documents
ATS Documents Editor
Professor of Medicine, Boston University School of Medicine
Notes for the viewer:
Here is a link to a video presentation by one of our guests on the steps to applying for an ATS document - https://vimeo.com/1089163046?share=copy [vimeo.com]00:00:00 – Introduction & podcast overview
00:02:02 – What the ATS podcast is about / host intro
00:03:06 – Overview of ATS document types
00:06:12 – Differences: clinical guidelines vs statements
00:09:18 – Examples of documents from the assembly
00:12:24 – How to propose a document (first steps)
00:15:30 – Building a strong proposal & team structure
00:18:36 – Methodology requirements & guideline process
00:21:42 – Submission, review, and scoring process
00:24:48 – Final decisions, tips, and process updates -
March 10, 2026
Description: In this episode of our Foundations of PH series, Dr. Ryan Tedford joins us to discuss the evolving hemodynamic definitions of pulmonary hypertension and its clinical implications. We also review right heart catheterization techniques, provocative hemodynamic testing, and pearls for right heart catheterization interpretation.
Hosts:
Khushboo Goel, MD
Assistant Professor of Medicine
Cedars-Sinai Medical CenterKatherine Cox-Flaherty, MD
Assistant Professor of Medical Education
University of Virginia
Inova FairfaxGuest:
Ryan Tedford, MD
Professor of Medicine/Cardiology
Chair, Heart Failure Program
Medical Director, Cardiac Transplantation Program
Medical University of South Carolina00:00 — Podcast Introduction & Hosts
00:22 — Episode Overview: Hemodynamic Definitions of Pulmonary Hypertension
01:00 — Guest Introduction: Dr. Ryan Tedford
01:25 — Career Path into Pulmonary Vascular Disease
02:48 — Why Hemodynamic Assessment Is Essential in PH
04:22 — Clinical Case Presentation: Suspected PH in Systemic Sclerosis
06:00 — Right Heart Catheterization: Indications, Risks & Contraindications
08:38 — Interpreting Hemodynamics & Classifying Pulmonary Hypertension
10:37 — Updated Hemodynamic Definitions from Recent Guidelines
15:45 — Advanced Right Heart Cath Techniques: Vasoreactivity, Fluid Challenge & Shunt Evaluation -
In this episode we will review tracheostomies in the critically ill. We will describe the patient selection, procedure, possible complications, and follow up care.
Host: Matthew Stutz, MD, MScBMI, Cook County Health, Assistant Professor Rush University, Chicago, Illinois
Guest: Elliot Backer, MD, Assistant Professor of Medicine, Geisel School of Medicine, Dartmouth
00:00:00 — Podcast Introduction & Disclosures
00:00:21 — Topic Overview & Guest Introduction (Tracheostomy in Critical Illness)
00:01:00 — Guest Background & Clinical Experience
00:01:51 — Case Presentation & Indications for Tracheostomy
00:06:42 — Timing, Evidence, and Techniques of Tracheostomy
00:19:59 — Patient Selection & Risk Stratification for Percutaneous Tracheostomy
00:20:37 — Imaging & Ultrasound to Reduce Bleeding Risk
00:22:05 — Early Post-Tracheostomy Complications: Bleeding & Dislodgement
00:26:20 — Tracheo-Innominate Fistula: Recognition & Emergency Management
00:35:20 — Post-ICU Outcomes, Prognosis, and Multidisciplinary Tracheostomy Care -
Tune into our next episode of the Foundations of PH series with PH expert Dr. Raymond Benza who walks us through the approach, importance, and treatment implications of risk stratification for patients with pulmonary hypertension.
Host: Kathryn del Valle MD, Mayo Clinic, Rochester, MN
Guest: Raymond Benza MD, Chief of Cardiology at Eastern Virginia Medical School and Academic Chair of Cardiology with Sentara Health
00:00 — Podcast Introduction & Foundations of PH Series
00:15 — Host Introduction and Episode Focus
00:34 — Guest Introduction: Dr. Raymond Benza
00:58 — Career Path and Early Exposure to Pulmonary Hypertension
02:15 — Evolution of PH Care and the Rationale for Risk Stratification
03:57 — Why Risk Stratification Matters for Patients and Treatment Decisions
06:24 — Clinical, Functional, Laboratory, and Imaging Tools for Risk Assessment
09:55 — Validated Risk Scores and Use at Baseline vs Follow-Up
14:58 — Risk Stratification Across PH Groups and Model Limitations
18:39 — Case-Based Discussion: High-Risk PAH Patient Evaluation, Hemodynamics, and Treatment Strategy -
The podcast was a brief overview of mechanisms that facilitate lung repair during ARDS to resume normal lung function. These included cells and their secreted products such as, Tregs, Macrophages, and Neutrophils, pro-resolving lipid mediators, and cytokines (IL-10, Tgf-b), along with active processes, such as efferocytosis and changes in immunometabolism. We discussed defining ARDS, factors that contribute to lung resolution, and ended with potential therapeutic options for actively promoting repair along with dampening the inflammatory response.
Moderators:
Filiz T. Korkmaz, PhD, Assistant Professor, University of Iowa
Hong Yong Peh, PhD, Research Assistant Professor, National University of SingaporeDiscussants:
Bruce D. Levy, M.D., M.Sc.(Hon.), Hersey Professor of the Theory and Practice of Physic, Harvard Medical School, Executive Vice-Chair, Mass General Brigham, Department of Medicine, Brigham and Women’s Hospital
Kymberly Gowdy, PhD, Associate Professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, The Ohio State University
Benjamin Singer, MD, Vice Chair for Research, Department of Medicine, Lawrence Hicks Professor of Pulmonary Medicine, Associate Professor, Medicine (Pulmonary and Critical Care), Biochemistry and Molecular Genetics00:00 — Introduction & Topic Overview
01:30 — Defining ARDS: Clinical vs Mechanistic Perspectives
05:30 — Resolution vs Recovery vs Repair
08:30 — Pro-Inflammatory Mediators & Neutrophil Biology
13:30 — Pro-Resolving Pathways & Specialized Lipid Mediators
19:55 — Regulatory T Cells, IL-10, and Efferocytosis
22:30 — Macrophage Plasticity and the Limits of the M1/M2 Paradigm
27:30 — Pro-Inflammation and Pro-Resolution Occur in Parallel
33:30 — Aging, Immune Dysfunction, and Impaired Resolution
39:30 — Knowledge Gaps and Future Therapeutic Directions in ARDS -
In this episode, we share the wisdom of Dr. Lauren Kearney, a BSHSR member, in her strategies for success in community engaged research and making the most of ATS membership.
00:00 – Podcast Opening & Guest Introduction
00:33 – Dr. Kearney's Award & Early-Career Transition
02:03 – Research Focus: Equity, Community Engagement, Smoking Cessation
04:08 – Mentorship Influence & Diverse Training Experiences
06:06 – Entering Community-Engaged Research: Mentors & Skills
08:01 – Value of ATS Membership: Sponsorship & Access to Leaders
10:01 – Navigating ATS as a Trainee & Becoming Involved
12:07 – Practical Advice for Planning ATS Meeting Engagement
14:14 – Overcoming Nervousness & Preparing an Elevator Pitch
17:10 – Peer Community, Continued Growth, & Closing Remarks -
In this episode of the Elevator Pitch, brought to you by the ATS Critical Care Assembly, we talk to Dr. Kevin Buell about his work using machine learning to predict optimal oxygenation targets for critically ill patients.
Host: Divya Shankar, MD, Boston University
Guest: Kevin Buell, MBBS, University of Chicago00:00 Introduction to the Podcast
00:31 Meet Dr. Kevin Buell
01:37 Dr. Buell's Research Interests
02:08 Elevator Pitch: Oxygen Targets Study
03:08 Study Methodology and Results
05:08 Limitations and Machine Learning
07:08 Model Validation and Application
16:19 Future of Machine Learning in Medicine
17:48 Conclusion and Takeaways
19:13 Closing Remarks -
This is the second episode of our Advocacy Series — a collection of podcasts dedicated to exploring key issues in pediatric pulmonology.
In this episode, Robyn Cohen, MD, MPH, and Will Feldman, MD, DPhil, MPH, share their experiences in policy-related advocacy, focusing on inhaler policy, including topics related to Flovent (Fluticasone). They discuss recent developments, challenges, and barriers in inhaler policy, as well as practical tips and strategies for engaging in policy work.
00:00 – Podcast Opening, Hosts, Topic Setup & Guest Introductions
02:40 – Early Experiences, Origins of Inhaler Advocacy & Media Attention
05:00 – Pediatric vs Adult Perspectives, Policy Challenges & Initial Industry/Regulatory Issues
10:00 – Ongoing Aftermath of Inhaler Discontinuations, Community Impact & System Barriers
15:00 – Market Forces, Dry-Powder Alternatives, Patents & Device Innovation Limitations
19:57 - Patent Protection, New Products, and Market Incentives
22:01 - Environmental Concerns, Formularies, and Clinician Constraints
24:03 - Recommended Resources and Understanding Patents/PBMs
26:09 - Advocacy Challenges, Publishing Op-Eds, and Media Engagement
29:04 - Policy Barriers, Authorized Generics, and Institutional Advocacy SupportAdditional Resources:
Dr. Feldman’s Testimony regarding pharmaceutical patents before the Senate Judiciary Committee:
https://www.judiciary.senate.gov/committee-activity/hearings/ensuring-affordable-and-accessible-medications-examining-competition-in-the-prescription-drug-marketA version of Dr. Feldman’s written testimony:
https://pubmed.ncbi.nlm.nih.gov/40197405/Letter in Peds Pulmonology describing the experience of inhaler advocacy:
https://pubmed.ncbi.nlm.nih.gov/40105398/
Cohen RT, Christy Sadreameli S, Coates AC, Nelson BA, O'Sullivan BP; Members of the Advocacy Subcommittee of the American Thoracic Society Pediatrics Assembly and the New England Pediatric Pulmonary Consortium. Ensuring Inhaler Access for Children: A Case Study in Advocacy by Pediatric Pulmonologists. Pediatr Pulmonol. 2025 Mar;60(3):e71055. doi: 10.1002/ppul.71055. PMID: 40105398.Op-Ed from Drs. Christy Sadreameli and Dr. Robyn Cohen:
https://www.usnews.com/opinion/articles/2024-04-18/asthma-inhaler-chaos-leaves-us-doctors-and-the-children-we-treat-out-of-breath -
This episode marks the launch of our Advocacy Series, a collection of podcasts dedicated to exploring key issues in Pediatric Pulmonology. In this episode, Dr. Abby Nerlinger and Dr. Anita Shah discuss how to build an effective advocacy portfolio and provide practical guidance for academic advocacy promotion.
Guest
Dr. Abby Nerlinger, MD MPH
Pediatric Hospitalist
Nemours Children’s Hospital, Wilmington, DEGuest
Dr. Anita Shah, DO MMS MPH
Pediatric Hospitalist
Cincinnati Children’s Hospital Medical Center, Cincinnati, OHHost
Dr. Anne Coates, MD
Pediatric Pulmonologist.
Maine Health, Portland, MEHost
Dr. S. Christy Sadreameli, MD MHS
Pediatric Pulmonologist
Johns Hopkins University School of Medicine, Baltimore, MDHost
Dr. Matt Wong, DO MPH
Pediatric Pulmonologist.
Children’s Hospital of Los Angeles, Los Angeles, CA
00:00 — Podcast & Host Introductions
00:22 — Episode Focus: Advocacy Portfolios & Academic Promotion
00:41 — Guest Introductions: Dr. Abby Nirlinger & Dr. Anita Shah
01:29 — Backgrounds, Training & Advocacy Roles of Guests
05:11 — Paths Into Advocacy (Shah & Nirlinger)
09:19 — Integrating Advocacy Into Academic Work
15:06 — Origins & Structure of the Advocacy Portfolio
18:57 — Building Evidence & Community Engagement in Advocacy
21:31 — Aligning Advocacy With Institutions, Funding & Protected Time
30:29 — Advocacy Impact: Health Outcomes, Skills, Burnout & Public Messaging -
Nov 21, 2025
Tune into Practical PH’s inaugural episode of the Foundations of PH series with PH expert Dr. Namita Sood who takes us through a systematic approach of accurately diagnosing pulmonary hypertension.00:00 — Podcast Welcome & Series Overview
01:05 – Guest Introduction & Journey Into PH
03:23 – Patient Case Introduction & Key History
06:20 – Physical Exam Findings & Early Risk Assessment
09:04 – Essential Diagnostic Approach
11:40 – Workup Results & ILD Interpretation
15:01 – Next Steps: ILD Care & Right-Heart Cath
17:01 – Group 3 PH Evaluation & Management
20:08 – Treatment Options & Inhaled Treprostinil
22:46 – Key Takeaways & Closing -
Dr. Joanne McKell, MD interviews Dr. Erika Moseson, MD, MA physician and podcaster, about her road to environmental advocacy despite a heavy clinical and administrative workload, a pandemic, and a young family. Dr. Moseson is the creator and host of Air Health, Our Health, a host of the ATS podcast Out of the Blue, and member of the ATS Environmental Health Policy committee.
*Produced by the EOPH Assembly
(00:00) - Introduction to the EOPH Assembly Podcast(01:08) - Dr. Erica Moseson’s Journey into Medicine(03:13) - Balancing Family, Career, and Advocacy(07:00) - Physician Well-Being and Purposeful Advocacy(10:10) - From Local Activism to the “Air Health, Our Health” Platform(19:55) - From Plasma Waves to Practical Solutions(20:20) - Building “Twitchy Airways Club” and the Ethics of Sharing(21:27) - Engaging Patients Through Podcasts and Videos(24:29) - Advocacy Starts at Home: Making Local Impact Count(31:09) - Teaching Climate and Health in Medical EducationHost: Joanne McKell, MD, Case Western Reserve University School of Medicine
Guest: Erika Mosesón, MD, MA, Pulmonary Section Chair at Legacy Emanuel Health Medical Center -
In this episode, Dr. Joanne McKell, MD sits down with Dr. Mary Rice, MD, MPH Chair of the Environmental, Occupational, and Population Health (EOPH) Assembly of the American Thoracic Society. Dr. Rice shares her journey into environmental health, her goals as Chair, and how her clinical work in pulmonary medicine informs her research on air pollution and climate change.
*Produced by the EOPH Assembly
00:01:20 | Early Influences & Environmental Awareness
00:02:30 | From Consulting to Medicine
00:03:30 | The Path to Pulmonary Medicine
00:04:50 | Joining and Leading Within ATS
00:06:10 | Inside the Role of an Assembly Chair
00:07:50 | Goals for the Year Ahead
00:09:10 | The Power of Framing in Science Communication
00:10:50 | Balancing Clinical Practice and Leadership
00:12:30 | Optimism, Perseverance, and Closing ReflectionsHost: Joanne L. McKell, MD, Case Western Reserve University School of Medicine
Guest: Mary B. Rice, MD, MPH, Harvard Medical School, Harvard TH Chan School of Public Health -
An in-depth exploration of the evolving understanding of inflammation in COPD, focusing on the differences between type 1/3 and type 2 inflammatory pathways and their clinical relevance. Experts will discuss current gaps in COPD management and the potential of precision medicine to improve outcomes for patients with persistent symptoms or frequent exacerbations. The program will also review recent clinical trial data on type 2 biologics, strategies for identifying appropriate candidates through biomarkers and comorbidities, and key areas for future research, including long-term outcomes, treatment tapering, and therapy optimization.
* Produced by the AII Assembly
Host:
• Sara Assaf, MD - Assistant Professor, Division of Pulmonary, Critical Care and Sleep at the University of New Mexico
Guests
• Nick Hanania, MD, MS - Director, Airways Clinical Research Center, Brown Foundation, Professor of Medicine, Baylor College of Medicine
• Stephanie Christenson, MD MAS - Associate Professor, Division of Pulmonary, Critical Care, Allergy, & Sleep, UCSF
• Surya P Bhatt MD, MSPH - Professor of Medicine, Endowed Professor of Airways Disease, University of Alabama at Birmingham
• Klaus Rabe, MD, PhD, FERS - Professor of Pulmonary Medicine, University of Kiel🔹 00:00:00 | Introduction (0–4 min)
🔹 00:04:04 | Setting the Stage: Why Type 2 Inflammation Matters in COPD
🔹 00:08:07 | The Science Behind COPD and Type 2 Pathways
🔹 00:12:08 | How Inflammation Shapes Disease Progression
🔹 00:16:11 | Current and Emerging Treatments for COPD
🔹 00:24:20 | Biomarkers and Precision Medicine
🔹 00:32:25 | New Frontiers and Ongoing Research
🔹 00:52:41 | Wrapping Up and Key Takeaways -
Field walking tests are common outcome measures used in pulmonary rehabilitation to measure an individual's exercise capacity. With a growing number of other outcome measures that also assess exercise capacity, should people still continue to use field walking tests? This podcast aims to highlight why field walking tests should still be used and the common pitfalls when executing these tests.
00:00 – Introduction
02:10 – Why Field Walking Tests Matter
06:25 – The Big Three Tests
12:40 – Choosing the Right Test
13:20 – Limitations of Current Field Tests
13:35 – Emerging Role of Step Tests
15:05 – Three Key Takeaways (Dr. Machado)
16:45 – Closing Remarks
17:30 – Outro**Produced by the PR Assembly
-
The intersection of pulmonary and palliative medicine is particularly relevant in the care of patients with interstitial lung disease (ILD). The complex medical, psychological, and physical needs of this population necessitate a collaborative approach, integrating the expertise of both specialties. Approaching care with curiosity rather than judgment fosters interdisciplinary partnership, leading to more comprehensive, patient-centered strategies that enhance outcomes for ILD patients and their caregivers across all dimensions of care.
#PulmonaryPalliativeCare
#AdvancedLungDisease
#InterstitialLungDisease
#Partnerships #Collaboration
#PalliativeMedicine #ATS #AAHPM #WESCOEfoundation #AdvancedIllnessPlanning #GoalsOfCare #TeamBasedCare #WholePersonCare #BeCuriousNotJudgmental*Produced by the BSHSR Assembly
